Gemma A Figtree
Overview
Explore the profile of Gemma A Figtree including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
223
Citations
3262
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu J, Indraratna P, Briggs N, Brown P, Liu H, Atkins E, et al.
Am Heart J
. 2025 Mar;
PMID: 40081743
Background: Digital health interventions have potential to improve outcomes in high risk cardiac patients through remote monitoring and patient education but introduce accessibility issues among patients who lack suitable smartphones....
2.
Parmenter B, Kavurma M, Richards T, Arnott C, Aitken S, Wise S, et al.
Heart Lung Circ
. 2025 Feb;
34(3):225-234.
PMID: 39919990
Peripheral arterial disease (PAD) is characterised by atherosclerotic stenosis or occlusion of arteries that leads to reduced blood flow to the limbs. PAD is associated with a very high rate...
3.
Beharry J, Yogendrakumar V, Barros G, Davis S, Norrving B, Figtree G, et al.
Eur Stroke J
. 2025 Jan;
:23969873241309516.
PMID: 39745075
Introduction: Little is known of the long-term prognosis of patients with acute ischaemic stroke in the absence of standard modifiable stroke risk factors (SMoRFs). In acute coronary syndromes, patients without...
4.
Chew N, Mehta A, Goh R, Zhang A, Chen Y, Chong B, et al.
Circulation
. 2024 Dec;
151(1):98-119.
PMID: 39723980
There is a new awareness of the widespread nature of metabolic dysfunction-associated steatotic liver disease (MASLD) and its connection to cardiovascular disease (CVD). This has catalyzed collaboration between cardiologists, hepatologists,...
5.
Anand V, Koh J, Teo T, Chin Y, Mahesh R, Chan M, et al.
Clin Res Cardiol
. 2024 Nov;
PMID: 39531081
Purpose: This meta-analysis investigates the sex differences in mortality risk between the acute coronary syndrome (ACS) population without standard modifiable risk factors (SMuRF-less) and those with at least one standard...
6.
Lee W, Genetzakis E, Barsha G, Vescovi J, Mifsud C, Vernon S, et al.
Biomolecules
. 2024 Oct;
14(10).
PMID: 39456241
Background And Aims: Myeloperoxidase (MPO) plays a critical role in the innate immune response and has been suggested to be a surrogate marker of oxidative stress and inflammation, with elevated...
7.
Figtree G, Doyle K, Nedkoff L, Cadilhac D, Kovacic J
Med J Aust
. 2024 Oct;
221(9):452-456.
PMID: 39403774
No abstract available.
8.
9.
Bate K, Genetzakis E, Vescovi J, Gray M, Celermajer D, McGuire H, et al.
Biomolecules
. 2024 Sep;
14(9).
PMID: 39334884
The risk-factor-based prediction of atherosclerotic coronary artery disease (CAD) remains suboptimal, particularly in the absence of any of the standard modifiable cardiovascular risk factors (SMuRFs), making the discovery of biomarkers...
10.
La Gerche A, Paratz E, Bray J, Jennings G, Page G, Timbs S, et al.
Heart Lung Circ
. 2024 Sep;
33(11):1507-1522.
PMID: 39306551
Sudden cardiac arrest (SCA) represents a major cause of premature mortality globally, with enormous impact and financial cost to victims, families, and communities. SCA prevention should be considered a health...